Literature DB >> 9164400

A guide to interpreting discordant systematic reviews.

A R Jadad1, D J Cook, G P Browman.   

Abstract

Systematic reviews are becoming prominent tools to guide health care decisions. As the number of published systematic reviews increases, it is common to find more than 1 systematic review addressing the same or a very similar therapeutic question. Despite the promise for systematic reviews to resolve conflicting results of primary studies, conflicts among reviews are now emerging. Such conflicts produce difficulties for decision-makers (including clinicians, policy-makers, researchers and patients) who rely on these reviews to help them make choices among alternative interventions when experts and the results of trials disagree. The authors provide an adjunct decision tool--a decision algorithm--to help decision-makers select from among discordant reviews.

Entities:  

Mesh:

Year:  1997        PMID: 9164400      PMCID: PMC1227410     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  95 in total

Review 1.  The need for caution in interpreting high quality systematic reviews.

Authors:  K Hopayian
Journal:  BMJ       Date:  2001-09-22

Review 2.  Randomized controlled trials and neuro-oncology: should alternative designs be considered?

Authors:  Alireza Mansouri; Samuel Shin; Benjamin Cooper; Archita Srivastava; Mohit Bhandari; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2015-08-22       Impact factor: 4.130

Review 3.  Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.

Authors:  Giuseppe G L Biondi-Zoccai; Marzia Lotrionte; Antonio Abbate; Luca Testa; Enrico Remigi; Francesco Burzotta; Marco Valgimigli; Enrico Romagnoli; Filippo Crea; Pierfrancesco Agostoni
Journal:  BMJ       Date:  2006-01-16

Review 4.  A systematic review of conflicting meta-analyses in orthopaedic surgery.

Authors:  Patrick Vavken; Ronald Dorotka
Journal:  Clin Orthop Relat Res       Date:  2009-02-28       Impact factor: 4.176

5.  Role of technology assessment in orthopaedics.

Authors:  Charles Turkelson; Joshua J Jacobs
Journal:  Clin Orthop Relat Res       Date:  2009-04-30       Impact factor: 4.176

Review 6.  Development of the Veritas plot and its application in cardiac surgery: an evidence-synthesis graphic tool for the clinician to assess multiple meta-analyses reporting on a common outcome.

Authors:  Sukhmeet S Panesar; Christopher Rao; Joshua A Vecht; Saqeb B Mirza; Gopalakrishnan Netuveli; Richard Morris; Joe Rosenthal; Ara Darzi; Thanos Athanasiou
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

7.  Replicate systematic review and meta-analyses on robotic surgery: a quality appraisal and overlap investigation.

Authors:  Jin Ji; Han Zhang; Da Xu; Tianyi Zhang; Depei Kong; Guang'an Xiao; Zhi Cao; Fubo Wang; Xu Gao; Ying-Hao Sun
Journal:  Surg Endosc       Date:  2019-04-10       Impact factor: 4.584

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

9.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 10.  Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses.

Authors:  Bas P L Wijnhoven; Jan J B van Lanschot; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.